Enhanc3D Genomics is a startup based in the United Kingdom, 1 tracked investor.
Based in the United Kingdom, Enhanc3D Genomics is a startup founded in 2018. Brouky records 1 investor associated with the company.
Enhanc3D Genomics is a functional genomics company that utilizes a proprietary 3D genomics platform to discover novel drug targets and biomarkers by identifying non-coding regulatory elements in disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.